Localisation of Hodgkin's disease and lymphomas by 67-gallium substraction scanning.

Abstract:

:67Ga-subtraction scan was found to be useful and a promising new method for the pre-treatment evaluation of the patient with Hodgkin's disease or non-Hodgkin's lymphoma. The scan appeared to be most accurate in the neck, chest, and axillary regions. It appears to offer a means of increasing the accuracy of evaluating the abdomen, the para-aortic and pelvic regions. It may be a useful method for the follow-up to detect recurrences. It was an easily performed, safe, non-invasive test, well tolerated and accepted by patients.

journal_name

Oncology

journal_title

Oncology

authors

Krolikiewicz H,Maruyama Y,Deland FH,Beihn RM,Hafner T,Utley JF

doi

10.1159/000225217

subject

Has Abstract

pub_date

1977-01-01 00:00:00

pages

179-84

issue

4

eissn

0030-2414

issn

1423-0232

journal_volume

34

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Accumulation of 111In-bleomycin in metastatic lesions from carcinoma of the uterine cervix and the ovary.

    abstract::Cases are presented in which 111In-bleomycin accumulated in Virchow's gland metastasis from squamous cell carcinoma of the uterine cervix, and in paratracheal lymphatic gland metastasis from embryonal carcinoma of the right ovary. Thus, this radiopharmaceutical was found to be of great use for assessment of metastatic...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226373

    authors: Kida T,Ikeda M

    更新日期:1986-01-01 00:00:00

  • DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.

    abstract:OBJECTIVE:Oncogene-driven stress-related DNA damage has been observed in lesions of colon cancer. Furthermore, DNA sensors and nucleases are stimulated during active DNA damage and replication. However, their changes and influences with respect to cancer remain largely unknown. METHODS:The gene expression levels of cG...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000452281

    authors: Yang CA,Huang HY,Chang YS,Lin CL,Lai IL,Chang JG

    更新日期:2017-01-01 00:00:00

  • The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma.

    abstract:OBJECTIVES:A germline BIM deletion polymorphism has been proposed to predict a poor treatment efficacy of certain kinase inhibitors. The current study aimed to explore whether the BIM deletion polymorphism predicts the treatment efficacy of sorafenib for advanced hepatocellular carcinoma (HCC). METHODS:All patients wh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000356019

    authors: Shao YY,Chang YL,Huang CY,Hsu CH,Cheng AL

    更新日期:2013-01-01 00:00:00

  • Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer.

    abstract:BACKGROUND AND OBJECTIVES:Even though the pathological background contributes to lymph node metastasis, the biological characteristics of tumors have also gained wide attention. In this study, the expression of the cadherin-catenin complex and p53 was studied in early gastric cancer. Their correlation with lymph node m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012020

    authors: Xiangming C,Hokita S,Natsugoe S,Tanabe G,Baba M,Takao S,Kuroshima K,Aikou T

    更新日期:1999-01-01 00:00:00

  • Aspirin shares a short-term effect, inhibition of pyruvate kinase activity with tumor-promoting agents, but fails to promote rat liver carcinogenesis.

    abstract::Since aspirin was found to cause a persistent decrease in pyruvate kinase activity, which is a prominent characteristic of the hepatic promoters, the effect of aspirin on hepatic tumorigenesis in the rat has been studied. Male Wistar rats were initiated with a diet containing 0.06% 3'-methyl-4-dimethylamino-azobenzene...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227195

    authors: Yanagi S,Yamashita M,Hiasa Y

    更新日期:1993-07-01 00:00:00

  • Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.

    abstract:OBJECTIVE:We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer QLQ-PR25 when applied to Korean prostate cancer (PC) patients. METHODS:A total of 172 patients who underwent curative radical prostatectomy (RP) with or without adjuvant androgen d...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000355689

    authors: Park J,Shin DW,Yun SJ,Park SW,Jeon SS,Kwak C,Kwon TG,Kim HJ,Ahn H

    更新日期:2013-01-01 00:00:00

  • Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer.

    abstract:OBJECTIVES:The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an indicator of cancer-related inflammation. The aim of our study was to examine the prognostic value of the NLR for patients with advanced gastric cancer receiving second-line chemotherapy. METHODS:The association of overall survival (OS) in sec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000493427

    authors: Inoue D,Sekiguchi S,Yamagata W,Maeda G,Yamada D,Fujiwara S,Itou S,Kurihara M,Hijioka Y,Shimoji K,Fujiki J,Nakazono A,Horike H,Yoshioka A,Ogura Y,Hatao F,Imamura K,Namiki S

    更新日期:2019-01-01 00:00:00

  • Immuno-Oncological Treatment and Tumor Mass in Non-Small Cell Lung Cancer: Case-Control Analysis of Overall Survival in Routine Clinical Practice.

    abstract:BACKGROUND:Immuno-oncological (IO) therapies such as PD-1 and PD-L1 antibodies have been introduced in the treatment of advanced non-small cell lung cancer (NSCLC) since 2015 based on randomized trials showing unprecedented advantages in overall survival (OS) with hazard ratios (HRs) between 0.5 and 0.7. The impact of ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000500885

    authors: Faehling M,Kopp M,Schwenk B,Fallscheer S,Kramberg S,Eckert R

    更新日期:2019-01-01 00:00:00

  • Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.

    abstract:OBJECTIVE:To evaluate the clinical and cost benefits of the administration of aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) during high-dose chemotherapy (HDCT). METHODS:We retrospectively reviewed the charts of patients who received HDCT at our institution between January 2009 and ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000479032

    authors: Nakamura A,Kojima Y,Miyazawa K,Matsumoto S,Iida H,Nagai H

    更新日期:2017-01-01 00:00:00

  • Testicular lymphoma: organ-specific treatment did not improve outcome.

    abstract:OBJECTIVES:To assess whether the use of an organ-specific treatment could improve event-free survival (EFS) and overall survival as endpoints in testicular lymphoma in the early stage: IE and IIE. METHODS:Thirty-four patients were selected to be treated with orchiectomy following six cycles of anthracycline-based comb...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000081319

    authors: Avilés A,Neri N,Huerta-Guzmán J,Pérez F,Fernández R

    更新日期:2004-01-01 00:00:00

  • Acute disseminated intravascular coagulation syndrome in cancer patients.

    abstract::Hemostatic abnormalities are rather frequent in cancer patients either in hematological or in solid tumors. Acute disseminated intravascular coagulation (DIC) is a rare coagulopathy in cancer patients, but when it develops it becomes rapidly fatal. Between June 1988 and December 1992 we observed 8 cases of acute DIC o...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227520

    authors: Pasquini E,Gianni L,Aitini E,Nicolini M,Fattori PP,Cavazzini G,Desiderio F,Monti F,Forghieri ME,Ravaioli A

    更新日期:1995-11-01 00:00:00

  • Lack of c-mpl proto-oncogene transcripts and growth-stimulatory effects of thrombopoietin on human small cell lung cancer cell lines.

    abstract::Thrombopoietin (TPO) is a recently discovered hematopoietic growth factor which stimulates the production and maturation of megakaryocytes. In this study, we used a modified MTT assay to examine the in vitro growth-stimulatory effects of recombinant human (rh) TPO and recombinant human stem cell factor (rhSCF) on eigh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227600

    authors: Shinohara A,Shimizu E,Takada M,Sone S

    更新日期:1996-09-01 00:00:00

  • Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.

    abstract::Etoposide is a highly schedule-dependent agent. We previously reported that a 21-day schedule of oral etoposide had good activity in small cell lung cancer (SCLC). The current phase II study was designed to test the combination of 21-day oral etoposide with cisplatin in hopes of capitalizing on etoposide's schedule de...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227108

    authors: Greco FA,Murphy PB,Hainsworth JD,Hande KR,Johnson DH

    更新日期:1992-01-01 00:00:00

  • Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.

    abstract:OBJECTIVE:To report the outcomes of surgical resection of borderline resectable (BL) and locally advanced (LA) 'unresectable' pancreatic cancer after neoadjuvant chemotherapy. METHODS:A review of a prospectively maintained database for pancreatic resections was undertaken to identify patients undergoing resection for ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000371745

    authors: Addeo P,Rosso E,Fuchshuber P,Oussoultzoglou E,De Blasi V,Simone G,Belletier C,Dufour P,Bachellier P

    更新日期:2015-01-01 00:00:00

  • Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion. I. Diagnostic value and use in battery of conventional tumor markers.

    abstract::C-reactive protein (CRP) has been found to be ubiquitous in sera when determined by a highly sensitive methods such as radioimmunoassay. Patients with some tumors appear to have much higher serum levels of CRP than others; in these, CRP seems to reflect the tumor burden. There is a positive correlation with TNM stagin...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225572

    authors: Drahovsky D,Dunzendorfer U,Ziegenhagen G,Drahovsky M,Kellen JA

    更新日期:1981-01-01 00:00:00

  • Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis.

    abstract:OBJECTIVE:BRAF D594G mutations in colorectal cancer patients are not clearly understood. We retrospectively investigated the clinicopathological features of colorectal cancers with BRAF D594G mutations. METHODS:We selected 908 colorectal cancer patients who underwent surgical resection from January 2008 to January 201...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000447402

    authors: Amaki-Takao M,Yamaguchi T,Natsume S,Iijima T,Wakaume R,Takahashi K,Matsumoto H,Miyaki M

    更新日期:2016-01-01 00:00:00

  • Is capecitabine efficacious in triple negative metastatic breast cancer?

    abstract:BACKGROUND:Recent data suggest that capecitabine may have little efficacy in women with metastatic triple negative breast cancer (TNT). We have therefore retrospectively analysed capecitabine outcome in the TN subgroup of patients with locally advanced or metastatic breast cancer treated in our unit. PATIENTS AND METH...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000323175

    authors: Kotsori AA,Dolly S,Sheri A,Parton M,Shaunak N,Ashley S,Walsh G,Johnston S,Smith IE

    更新日期:2010-01-01 00:00:00

  • Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancer.

    abstract::In order to assess the feasibility of a sequential hormonal treatment after tamoxifen failure, 24 postmenopausal advanced breast cancer patients (median age 60 years; ECOG PS < or = 1) were treated with formestane (4-hydroxyandrostenedione) 250 mg i.m. fortnightly; 19 patients were estrogen receptor-positive. The site...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227510

    authors: Noberasco C,Bajetta E,Zilembo N,Di Leo A,Cappuzzo F,Bartoli C,Bono A,Bichisao E

    更新日期:1995-11-01 00:00:00

  • Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB).

    abstract:BACKGROUND:This open-label, randomized phase III trial evaluated larotaxel/cisplatin versus gemcitabine/cisplatin as first-line treatment for locally advanced (T4b) or metastatic urothelial tract or bladder cancer. METHODS:Patients were randomized to larotaxel 50 mg/m(2) with cisplatin 75 mg/m(2) every 3 weeks (larota...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000354085

    authors: Sternberg CN,Skoneczna IA,Castellano D,Theodore C,Blais N,Voog E,Bellmunt J,Peters F,Le-Guennec S,Cerbone L,Risse ML,Machiels JP

    更新日期:2013-01-01 00:00:00

  • Prognostic value of syndecan-1 expression in breast cancer.

    abstract:OBJECTIVE:Syndecan-1 is a cell surface heparan sulphate proteoglycan which participates in cell proliferation, cell migration and cell-matrix interactions. Epithelial syndecan-1 expression is reduced in several malignant tumours, but in breast and pancreatic cancer, increased expression has also been described. Loss of...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000080280

    authors: Leivonen M,Lundin J,Nordling S,von Boguslawski K,Haglund C

    更新日期:2004-01-01 00:00:00

  • Low-dose aminoglutethimide therapy without glucocorticoid administration. Clinical and hormonal findings.

    abstract::Eleven postmenopausal patients with advanced breast cancer were assessed for their response and endocrine changes to low-dose aminoglutethimide (250 mg twice a day) therapy without steroid administration. In 7 cases an objective response was registered; 1 patient had a stabilization of the disease lasting for 9 months...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227006

    authors: Kahán Z,Tóth I,Vecsernyés M

    更新日期:1992-01-01 00:00:00

  • The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.

    abstract:BACKGROUND:Patients with localized gastric adenocarcinoma (LGAC), who get pre-operative therapy, have heterogeneous/unpredictable outcomes. Predictive clinical variables/biomarkers are not established. METHODS:We analyzed 107 LGAC patients who had chemoradiation and surgery. LGACs were grouped for (1) presence/absence...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000443506

    authors: Charalampakis N,Nogueras González GM,Elimova E,Wadhwa R,Shiozaki H,Shimodaira Y,Blum MA,Rogers JE,Harada K,Matamoros A Jr,Sagebiel T,Das P,Minsky BD,Lee JH,Weston B,Bhutani MS,Estrella JS,Badgwell BD,Ajani JA

    更新日期:2016-01-01 00:00:00

  • Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.

    abstract::Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were determined in 8 patients with disseminated testicular carcinoma before, during and 1 year after termination of a combination chemotherapy with cis-diamminedichloroplatinum (CDDP). The decrease in median GFR in comparison with the pretreatment...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000225718

    authors: Meijer S,Mulder NH,Sleijfer DT,Donker AJ,Sluiter WJ,de Jong PE,Schraffordt Koops H,van der Hem GK

    更新日期:1983-01-01 00:00:00

  • Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma.

    abstract:OBJECTIVE:Tyrosine kinase B (TrkB) is associated with aggressive behavior and poor prognosis in various cancers. Here we examined the association between TrkB expression and distant metastases/prognosis in gastric carcinoma (GC). PATIENTS AND METHODS:We analyzed TrkB expression in 161 GC patients by immunohistochemist...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151615

    authors: Zhang Y,Fujiwara Y,Doki Y,Takiguchi S,Yasuda T,Miyata H,Yamazaki M,Ngan CY,Yamamoto H,Ma Q,Monden M

    更新日期:2008-01-01 00:00:00

  • Inhibition of nitroso chemical carcinogen activation of rat hepatic guanylate cyclase by anticancer agents.

    abstract::Recent studies have demonstrated that nitroso chemical carcinogens activate guanylate cyclase (EC 4.6.1.2) which catalyzes the production of guanosine 3',5'-monophosphate. This nucleotide is thought to be involved in normal and abnormal cell growth. We examined the effect of 3 major classes of anticancer chemotherapeu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225362

    authors: Vesely DL,Levey GS

    更新日期:1979-01-01 00:00:00

  • Cancer of the esophagus. An incidence study of Côte d'Or (Burgundy).

    abstract::The registry of digestive cancer set up for the French department of Côte d'Or (455, 727) enables a morbidity study about esophageal cancer to be made among residents. The crude animal incidence rate was 16.7/100,000 for males and 1.2/100,000 for females. Corresponding age-standardized rates were 13.2 and 0.5. The sex...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225510

    authors: Faivre J,Milan C,Martin F,Michiels R,Cabanne F,Klepping C

    更新日期:1981-01-01 00:00:00

  • Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer.

    abstract:BACKGROUND:Brain metastases develop frequently in patients with non-small cell lung cancer (NSCLC), and the prognosis for these patients is very poor. We evaluated the role of chemotherapy for patients with brain metastases from NSCLC. METHODS:We analyzed 30 patients who were discovered to have brain metastases during...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012185

    authors: Fujita A,Fukuoka S,Takabatake H,Tagaki S,Sekine K

    更新日期:2000-11-01 00:00:00

  • Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.

    abstract:BACKGROUND:Over the last few years only one large randomized phase III study has tried to prospectively assess the safety of cetuximab and panitumumab in a head-to-head comparison. Despite the similar overall toxicity profile, cetuximab and panitumumab retain peculiar safety characteristics that deserve to be deeply in...

    journal_title:Oncology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1159/000486338

    authors: Petrelli F,Ardito R,Ghidini A,Zaniboni A,Ghidini M,Barni S,Tomasello G

    更新日期:2018-01-01 00:00:00

  • Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients.

    abstract:OBJECTIVE:This study reports the percentage of breast cancer survivors receiving ongoing benzodiazepines and the circumstances surrounding their usage. METHODS:The medical records of 1,000 consecutive breast cancer survivors who were no longer receiving adjuvant chemotherapy were reviewed. RESULTS:Among those patient...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000330814

    authors: Vaidya R,Sood R,Karlin N,Jatoi A

    更新日期:2011-01-01 00:00:00

  • Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.

    abstract:OBJECTIVES:Primary chemoradiotherapy for locally advanced pancreatic cancer (LAPC) may improve local control, curative resection rate and long-term survival. We performed a phase II study to evaluate toxicity and activity of primary radiation therapy and concurrent chemotherapy with gemcitabine (GEM) twice weekly in pa...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000086993

    authors: Magnino A,Gatti M,Massucco P,Sperti E,Faggiuolo R,Regge D,Capussotti L,Gabriele P,Aglietta M

    更新日期:2005-01-01 00:00:00